TruthArchive.ai - Related Video Feed

Mental disorders are metabolic disorders of the brain, correlating with rising obesity and diabetes rates. Mental disorders, including anxiety, depression, and schizophrenia, are now the leading cause of disability globally. Metabolism is often misunderstood; it encompasses more than just calorie burning and is fundamental to cell function, including brain cells. Chris Palmer shares the case of a patient, Tom, with schizoaffective disorder, who, after trying 17 medications without success, improved significantly on a ketogenic diet. Within weeks, Tom lost weight and reported a reduction in hallucinations and delusions, ultimately leading to a complete turnaround in his life. This experience challenged traditional psychiatric views, which often dismiss dietary interventions as ineffective. The increasing rates of mental illness over the past few decades are alarming, with about 20% of U.S. adults experiencing mental illness annually. During the pandemic, symptoms of depression and anxiety surged, with 40% of Americans reporting issues. Current treatments, including medications and therapy, only lead to remission in about 30% of cases, highlighting the inadequacy of existing approaches. Palmer emphasizes that mental disorders should be viewed through a metabolic lens, similar to heart disease. He argues that lifestyle factors, particularly diet, exercise, and sleep, significantly impact mental health. Mitochondrial dysfunction plays a crucial role in mental disorders, as it affects energy production in brain cells. Palmer advocates for a ketogenic diet as a therapeutic intervention, noting its potential to restore metabolic health and improve mental health outcomes. He shares success stories, including a woman named Doris, who achieved remission from schizophrenia after adopting the ketogenic diet. Palmer calls for a paradigm shift in mental health treatment, emphasizing the need for a grassroots movement to address these issues effectively. He encourages individuals to explore dietary interventions and engage in the conversation around mental health reform.

Alzheimer's disease has traditionally been viewed as a result of amyloid beta plaques and neurofibrillary tangles in the brain, which can only be confirmed postmortem. This has led to a need for a paradigm shift in understanding the disease. Emerging research suggests a metabolic theory of cognitive decline, indicating that markers of metabolic health, such as fasting insulin and glucose levels, may be more predictive of Alzheimer's risk than age. A Finnish study found that fasting insulin was a stronger predictor of Alzheimer's than age. The hippocampus, crucial for memory and learning, relies on glucose and ketones for energy. Insulin regulates glucose transport in the hippocampus, and as insulin resistance develops, the brain struggles to access glucose, leading to an energy deficit. This has led some researchers to label Alzheimer's as "type 3 diabetes," highlighting the connection between insulin resistance and cognitive decline. Insulin's role extends beyond glucose control; it affects every cell in the body. Chronic high carbohydrate intake leads to elevated insulin levels, causing insulin resistance and metabolic dysfunction. This dysfunction can manifest in various health issues, including cognitive decline, PCOS, and erectile dysfunction, all linked to insulin resistance. Research indicates that even in early cognitive decline, glucose metabolism in the brain is impaired while ketone metabolism remains intact. Studies show that dietary changes, particularly reducing carbohydrates and increasing healthy fats, can improve cognitive function. The food we consume plays a critical role in either exacerbating or alleviating chronic diseases, including Alzheimer's. To combat cognitive decline, individuals should focus on improving metabolic health through dietary changes, such as reducing refined carbohydrates and increasing healthy fats. This approach not only addresses Alzheimer's risk but also enhances overall well-being. The message is one of empowerment: individuals can take control of their health through informed dietary choices.

Dr. Georgia Ede, a Harvard-trained psychiatrist, discusses the significant impact of the ketogenic diet on mental health, noting that many individuals experience reduced anxiety within three days to three weeks of starting the diet. In a study involving patients with bipolar disorder, major depression, or schizophrenia, 43% achieved clinical remission, and 64% reduced their psychiatric medication. Ede emphasizes the importance of nutrition in mental health, highlighting that conventional psychiatric training often neglects the relationship between food and brain function. Ede defines her work as focusing on nutritional and metabolic psychiatry, a new field exploring how food affects brain metabolism and mental health. She identifies inflammation, oxidative stress, and insulin resistance as primary drivers of mental health conditions, challenging the traditional view of chemical imbalances. The ketogenic diet, originally developed to manage epilepsy, alters the brain's energy system, reducing inflammation and improving chemical balance. Ede explains that the diet can lead to profound brain healing over time. She shares her personal journey of health decline and subsequent dietary experimentation, which led her to discover the benefits of a low-carbohydrate, high-fat diet. Ede outlines three fundamental principles of nutrition: nourish, protect, and energize. She emphasizes the need for personalization in dietary choices, as individual metabolic health varies. Ede also discusses the potential of dietary changes to alleviate symptoms of ADHD, citing historical studies that show significant improvements in children with ADHD on restricted diets. While acknowledging the challenges of adhering to a ketogenic diet, Ede encourages individuals to explore dietary changes as a means to enhance mental health, asserting that understanding food's impact on the brain can empower people to make informed choices for their well-being.

Peter Attia and Dom D’Agostino explore the science, promise, and caveats of ketosis as a therapeutic and performance strategy. They trace Dom’s trajectory from neuroscience and naval research into the ketogenic space, detailing how high-oxygen environments, hyperbaric oxygen exposure, and redox biology illuminate brain energetics and seizure mechanisms. The conversation moves from foundational ketosis biology—how fasting, carbohydrate restriction, and beta-hydroxybutyrate shift brain fuel and gene regulation—to practical optimization: tracking ketones, proteins, and calories for athletes, the role of ketone esters versus ketone salts, and the need to balance electrolytes to prevent dehydration and dizziness during the transition to ketosis. They emphasize that nutritional ketosis is a metabolic therapy with pleiotropic effects, including neuroprotective signaling and anti-inflammatory potential, rather than a simple weight-loss protocol, and they stress individualized approaches guided by biomarkers and blood work. The discussion then broadens to exogenous ketones as a bridge and tool, addressing pharmacokinetics, enantiomers, and the tradeoffs of different formulations. They compare monoesters, diesters, and salts, explain the D- versus L- beta-hydroxybutyrate dynamics, and reveal how mixing ketones with MCTs or other compounds can modulate absorption, insulin response, and brain energy delivery. Dom candidly shares experimental cautions about liver load, energy toxicity, and the importance of dosing strategies that avoid insulin spikes while maintaining a stable 1–2 millimolar ketone range for cognitive and physical work. The pair also dives into applications for cancer and brain disorders, outlining a framework for glioblastoma and the glucose-ketone index, and they discuss how metabolic therapy could complement standard-of-care options while acknowledging the current absence of definitive randomized trials for many cancers and neurodegenerative diseases. They close with candid reflections on ongoing clinical research, regulatory hurdles, and the hope that metabolic approaches—together with targeted drugs and immune therapies—could meaningfully extend survival and improve quality of life in difficult conditions like GBM and Alzheimer’s disease.

Ketones function by opening escape valves in the body, leading to calorie wastage rather than efficient fat burning, which is key to weight loss. Steven Gundry's book, "Unlocking the Keto Code," presents keto as a longevity strategy, revealing that ketones are not an ideal fuel source. Research shows that while muscles initially prefer ketones during starvation, they soon switch to free fatty acids. Even in full ketosis, only a portion of energy needs are met by ketones, raising questions about their efficiency. The ketogenic diet, originally developed for epilepsy treatment, involves high fat intake and low carbohydrates, but many struggle to maintain it long-term. Gundry highlights that metabolic inflexibility affects many Americans, making it hard to enter ketosis. He shares a case of a patient who gained weight on a ketogenic diet due to insulin resistance, challenging the misconception that keto guarantees weight loss. Gundry emphasizes that a ketogenic diet can lead to inefficient fat burning, likening it to a Ferrari wasting fuel. He advocates for a balanced approach, incorporating fiber-rich and polyphenol-laden foods to support gut health and mitochondrial function. He discusses the importance of postbiotics and the role of gut bacteria in overall health. Ultimately, Gundry suggests a flexible dietary pattern that includes healthy fats, fiber, and polyphenols while avoiding processed foods and excess sugar. He underscores the significance of metabolic flexibility and the benefits of intermittent fasting to enhance ketone production and promote weight loss.

An alarming claim opens this conversation: 95% of Alzheimer's risk is environmental, not genetic, with the APOE4 component about 5%. Dr. Robert Lustig, a leading sugar researcher, describes a grocery landscape where 73% of items are poisoned by hidden sugars, with sugar named in more than 262 ways. He links sweeteners to dementia and notes that ultra-processed foods are associated with dementia, diabetes, cancer, and mental health disorders. Practical guidance follows: if a food has sugar listed in the first three ingredients, it is dessert; read labels as warning signals; never shop hungry. Exercise has metabolic benefits but does not guarantee weight loss, Lustig argues, and the idea of hostage brain centers on the amygdala's response to perceived loss of control, fueling a cycle of dopamine-driven cravings and pain, with depression affecting a sizable share of Americans. Explaining dopamine, Lustig outlines its twofold role in learning and reward and how chronic overstimulation reshapes brain receptors, producing tolerance and, eventually, addiction. He warns that even sugar substitutes can be harmful via reactive oxygen species, tying this to a broader theory in which mitochondria and ATP energy shortfalls trigger brain dysfunction. The proposed mechanism of neurodegeneration begins with an energy crisis in neurons, diverts glucose away from mitochondria, and promotes plaques and inflammation that culminate in neuronal loss. Ketones and ketogenic diets reduce cravings by altering fuel and improving mitochondrial function. Lustig and his team have developed a metabolic matrix—protect the liver, feed the gut, support the brain—and have begun re-engineering processed foods in Kuwait to be metabolically healthier while maintaining sales and profits. Toward practical action, the discussion emphasizes simple, repeatable steps Jenny and Dave can take: avoid shopping on an empty stomach, stick to the outer aisles, and treat foods with sugar as dessert. CGMs are cited as educational tools for non-diabetics, helping people see how different foods affect glucose and insulin. The talk delves into the gut-brain axis, noting that serotonin is largely produced in the gut and that stress and loneliness reduce serotonin signaling, impairing social connection and safety. Regular exercise expands mitochondrial capacity and brain-derived growth factors, while drugs like GLP-1 analogs are debated, favoring diet-driven, population-wide sugar reduction as the bigger public health win. The segment also touches psychedelics as serotonin mimickers that may help rewire entrenched beliefs, always with guidance, and underscores the need for credible information sources and a balanced public-health approach.

Tim Ferriss and David Baszucki (CEO of Roblox) discuss Baszucki's personal journey with his son's severe bipolar disorder, which spanned eight years, multiple hospitalizations, and numerous medications without significant improvement. A turning point came with the discovery of metabolic psychiatry and the implementation of a strict ketogenic diet, which led to remarkable progress within weeks. Baszucki recounts a harrowing incident where his manic son went missing, highlighting the extreme challenges faced by families dealing with severe mental illness. The conversation delves into the scientific basis of ketogenic diets, explaining how the body shifts from burning glucose to ketones for energy, providing a more consistent and clear energy source for the brain. This metabolic shift is posited as a potential solution for conditions linked to brain energy deficits, such as bipolar disorder, epilepsy, Alzheimer's (referred to as type 3 diabetes), and even cognitive symptoms of Lyme disease and OCD. Both hosts share personal experiences with ketosis, noting benefits like improved mental clarity, reduced need for sleep, enhanced breath-hold times, and a calmer, more optimistic outlook, emphasizing the importance of physiological interventions alongside traditional talk therapy. The discussion then transitions to Roblox, its genesis, and its vision for the future. Baszucki describes Roblox as a 3D gaming and communication platform with 120 million daily users, where all content is created by its community, ranging from hobbyists to professional teams earning millions. He highlights the platform's core mission to connect a billion users with optimism and civility, emphasizing its unique approach to safety for all ages, including young children, through filtered communication and strict monitoring. A pivotal business decision for Roblox was the early implementation of a digital economy using "Robux," which allowed creators to monetize their content and fostered a thriving ecosystem, directly correlating user engagement with revenue. Baszucki stresses the company's philosophy of prioritizing creator revenue and user engagement over maximizing short-term profits, viewing it as a long-term strategy for growth and community building. Looking ahead, Baszucki envisions Roblox evolving into a platform for virtual 3D work, music concerts, and even political rallies, moving beyond video calls to more immersive, real-time 3D interactions. He discusses the role of artificial intelligence in enhancing safety (e.g., age estimation, content filtering) and enabling future content creation, including procedurally generated real-time worlds. Both agree on the inevitability of many technological advancements, drawing parallels to past sci-fi predictions that have become reality. Baszucki also shares aspects of his personal self-care routine, which includes daily movement, sun exposure, very low alcohol intake, moderate ketosis, and consistent exercise like CrossFit and hiking. He advocates for continuous glucose monitors (CGMs) and continuous ketone monitors (CKMs) for metabolic health, noting Roblox provides CGMs to employees and labels snacks based on 'whole food' and 'good energy' axes, leading to significant positive health changes among staff. The conversation concludes with a reflection on the importance of 'feeding your head' through both physical and mental well-being.

In this episode of The Diary of a CEO, Steven Bartlett welcomes Benjamin Bikman, a leading metabolic scientist, to dissect how insulin orchestrates weight gain and how carbohydrate restriction and ketosis can reshape energy balance. The guest dispels the oversimplified “eat less, move more” paradigm, arguing that insulin’s role in energy storage is the pivotal lever for fat loss. He explains that two variables drive fat loss: shrinking fat cells and lowering insulin by reducing carbohydrate intake. The discussion traverses how insulin spikes suppress the brain’s access to energy from glucose and ketones, triggering hunger even when fat stores are plentiful. Bikman emphasizes that fat loss should come from protocols that minimize hunger and energy scarcity, highlighting that meals with the same calorie count but different macronutrient compositions yield different metabolic rates due to insulin’s regulation of energy use. He connects ketosis not only to fat burning but to diverse brain benefits, including reduced anxiety and improved attention, and shares how ketones serve as both fuel and signaling molecules that influence blood vessel dilation and brain chemistry. The conversation moves from practical diet design—structured indulgences around carb-rich holidays, prioritizing protein and fat to keep insulin low, and leveraging exogenous ketones during transitions—to the nuance of insulin’s supremacy in fat metabolism, illustrated with clinical anecdotes about type 1 diabetes and insulinoma to underscore how insulin control shapes outcomes. The host and guest explore the potential of breastfeeding-like clarity in patient education while acknowledging the complexities of real-world adherence, social media scrutiny, and evolving scientific discourse. Bikman also delves into the therapeutic potential of ketones for neurological and cardiovascular health, the role of exogenous ketones in preserving lean mass during weight loss, and the possibility of using GLP-1 therapies in a cycle with low-carb coaching to sustain long-term changes. They close with practical daily frameworks, including fasting, big lunch planning, regular resistance training, sleep optimization, and the impact of stress and testosterone on metabolic health, offering a holistic blueprint for listeners seeking a healthier 2026.

Dr. Steven Gundry emphasizes the critical role of gut health, asserting that "all disease begins in the gut," as stated by Hippocrates. He critiques the modern perception of whole grains as healthy, arguing that they contain harmful lectins that can lead to leaky gut. He notes that gluten, a lectin, is particularly damaging and can cause intestinal permeability, which is detrimental to cognitive health. Gundry highlights the dangers of glyphosate, commonly found in many foods, which contributes to leaky gut. He suggests opting for organic or biodynamic products to minimize exposure. He also advises against brown rice, stating it can exacerbate autoimmune conditions, favoring white basmati rice instead. The discussion shifts to sugar, with Gundry warning about its hidden presence in many foods, including those labeled as "sugar-free." He explains that fructose, often found in processed foods, is particularly harmful and can lead to insulin resistance. Gundry discusses the ketogenic diet, noting that while it can promote weight loss, it is not a guaranteed solution. He explains that ketones serve as a signaling mechanism for mitochondrial health rather than being an efficient fuel source. He advocates for metabolic flexibility and suggests compressing eating windows to enhance health and longevity. He emphasizes the importance of polyphenols from colorful plant foods, which support gut health and mitochondrial function. Gundry also highlights the benefits of medium-chain triglycerides (MCTs) for generating ketones and improving metabolic health. Finally, he discusses the significance of dairy fats, particularly from goat and sheep, which contain beneficial compounds for longevity and heart health. Overall, Gundry advocates for a balanced approach to diet, focusing on gut health, reducing harmful substances, and incorporating nutrient-rich foods.

The episode delves into ketosis as a tool for weight loss, mood stabilization, cognition, and potential neuroprotection, with Dr. Dom D’Agostino offering a practical, experience-based tour of how ketogenic fasting regimens influence brain chemistry and systemic metabolism. The conversation begins by outlining how ketosis shifts energy substrate use from glucose to fat-derived ketones, highlighting the diuretic and natriuretic effects that can lower blood pressure and fluid volume while reducing insulin resistance. The hosts discuss the brain’s response to ketones, including elevated GABA, dampened glutamate activity, and a resulting calming effect that underpins mood stabilization and seizure control. The discussion broadens to therapeutic contexts, including metabolic psychiatry and cancer care, where ketosis may slow glycolysis-tethered tumor growth and improve treatment responses. The speakers emphasize that ketosis is not a cure but a metabolic modulator with widespread effects—from anti-inflammatory actions to immune modulation and potential benefits for neurodegenerative risk factors. They also explore how intermittent fasting and metabolic memory may create lasting improvements in mitochondrial function, insulin sensitivity, and fat oxidation, suggesting a persistent “metabolic memory” that can persist beyond active dietary change. Throughout, the hosts address practicalities of following a ketogenic lifestyle: meal composition, macro balance, and strategies to minimize gluconeogenesis while preserving muscle. They discuss exogenous ketones, including monoesters and diesters, weighing palatability, pharmacokinetics, toxicity, and the risks of chronic high-dose use, particularly with 1,3-butanediol-based formulations. Close attention is paid to real-world monitoring tools such as CGMs and ketone meters, plus the importance of fiber, fat, and electrolyte management to sustain ketosis during meals. The broader message is that ketogenic strategies—when thoughtfully applied and personalized—can be powerful tools in improving brain function, mood, and longevity, albeit with careful consideration of dosage, timing, and individual physiology.

A ketogenic diet, a very low carbohydrate diet, has been used for nearly a century to treat epilepsy and is being studied for its potential benefits in Alzheimer's disease. The brain typically uses glucose for energy, but during fasting, it can utilize ketones from fat. While the ketogenic diet may help those with neurological conditions, there is no strong evidence linking it to longevity or optimal aging. It can be a therapeutic option for managing Alzheimer's, but a nutrient-dense diet is recommended for overall health.

Joe Rogan welcomes Dom D'Agostino to the podcast, discussing various aspects of the ketogenic diet. D'Agostino shares insights on a specific wine that can be consumed while maintaining ketosis, explaining that certain dry wines have low glycemic impact, allowing for moderate consumption without disrupting ketosis. He emphasizes the ketogenic diet's origins in treating pediatric epilepsy and its expanding applications, including conditions like polycystic ovary syndrome, acne, and genetic disorders such as Angelman syndrome. D'Agostino explains the science behind the ketogenic diet, which shifts the body's fuel source from carbohydrates to fats and ketones, a process that dates back to ancient practices of fasting. He discusses the physiological effects of fasting and ketosis, including enhanced brain energy production and resilience, particularly in extreme conditions. The conversation touches on the benefits of the ketogenic diet for various health issues, including its potential role in managing cancer and improving cognitive function. The discussion also highlights the importance of proper macronutrient ratios in the ketogenic diet and the challenges faced by those trying to adhere to it, particularly athletes. D'Agostino notes that while some athletes may struggle with performance on a strict ketogenic diet, others can adapt successfully with careful management of their carbohydrate intake. D'Agostino mentions ongoing research into the ketogenic diet's effects on migraines and wound healing, noting that ketones may have anti-inflammatory properties that aid in recovery. He emphasizes the need for further studies to validate the benefits of the ketogenic diet across various health conditions. The podcast concludes with D'Agostino sharing resources for those interested in the ketogenic diet, including websites and organizations dedicated to educating the public about its benefits. He encourages listeners to explore the ketogenic diet as a potential tool for improving health and managing various medical conditions.

The conversation between Max Lugavere and Dominic D’Agostino centers on the ketogenic diet and its profound effects on metabolic physiology and brain health. D’Agostino emphasizes that the ketogenic diet operates independently of calorie counts, significantly altering brain energy metabolism. He discusses his research on the diet's application for conditions like epilepsy and Alzheimer's disease, highlighting its potential to stabilize neurotransmission and improve cognitive function. D’Agostino shares insights from his work with NASA and underwater missions, noting how high CO2 levels in space can impair mitochondrial function and overall health. He also mentions the importance of continuous glucose monitoring in understanding metabolic responses and managing cravings, particularly for those with eating disorders. The discussion touches on the role of ketones in neuroprotection, particularly in the context of hypoglycemia, and the potential for ketogenic therapies to address various mental health disorders, including bipolar disorder and schizophrenia. D’Agostino notes the need for clinical trials to validate these findings and mentions the challenges of sustaining a strict ketogenic diet. He advocates for a modified Mediterranean ketogenic diet that includes fiber and phytonutrients, arguing that this approach can optimize metabolic health while still providing the benefits of ketosis. The conversation concludes with a focus on the importance of functional biomarkers over traditional lipid measurements in assessing health outcomes.

In this episode of The Diary of a CEO, Dr. Annette Bosworth joins host Steven Bartlett to unpack how insulin, ketones, and a ketogenic lifestyle influence brain health and aging, including the potential links to dementia and cognitive decline. The conversation centers on insulin as a chronic disease driver when levels stay chronically high, promoting weight gain, inflammation, and “trash” in the brain and body. Bosworth emphasizes practical changes to reduce insulin, notably moving calories to earlier in the day, minimizing late-night eating, and adopting a fat-forward, very low-carbohydrate approach that provokes ketone production. She explains that insulin resistance creates a metabolic environment where the body preferentially stores sugar as glycogen or fat, making it difficult to switch to fat-derived ketones even during fasting. The dialogue pivots to how ketones can act as a cleaner, more efficient fuel for brain cells, potentially slowing or altering the trajectory of neurodegenerative conditions like Alzheimer’s, though she cautions that long-term causality remains unsettled and that results vary among individuals. A running theme is the difference between short-term dieting and a sustainable, medically supervised ketogenic strategy—referred to as the Keto Continuum—which outlines steps from initial carbohydrate reduction to extended fasting windows and strategic meal timing. Throughout, Bosworth shares clinical anecdotes, including dramatic stories of weight loss, improved energy, sharper cognition, and even apparent reversal of gray hair in some patients, all attributed to reduced insulin and higher ketone availability. She also discusses the role of the gut-brain axis, noting that fat-rich diets influence gut microbes and metabolites like butyrate that can modulate GLP-1 signaling and appetite. The interview weaves in personal experiences, such as Bosworth’s 21-day course and a 100-day sardine challenge intended to drive a deep metabolic reset, while addressing common concerns about sustainability, social life, gender differences, and the interaction of diet with medications like GLP-1 agonists. The episode ends with reflections on motivation, crisis-to-growth mental models, and Bosworth’s broader message: when insulin resistance is lowered and ketones are regularly produced, people can experience clearer thinking, steadier energy, and a higher quality of life, even as they navigate complex health challenges and life’s inevitable obstacles.

Fasting emerges as a powerful medical tool in this conversation, with Dr. Alan Goldhammer arguing that water-only fasting can reverse hypertension, rebalance insulin resistance, and reset the gut. Over four decades, he has guided thousands to health by using one of humanity’s oldest healing practices, including a landmark study in which 174 consecutive patients with high blood pressure normalized their readings without medication. He describes fasting as complete abstinence from all substances in a resting state, emphasizing that rest minimizes lean-tissue loss while maximizing fat loss. He distinguishes water fasting from juice fasting, noting that the latter is a modified diet, and he asserts that the most dramatic metabolic changes—BDNF increases, autophagy, and improved brain function—often accompany fasting just as they do with exercise. He also stresses that the goal is to avoid dietary excess, not merely to restrict calories. Mechanistically, the dialogue traces the fasting sequence from glycogen depletion after about a day to a brain that switches from glucose to ketones as a primary fuel, with beta-hydroxybutyrate supporting cognitive stability and elevated BDNF. Autophagy is introduced as housekeeping cellular cleanup, while visceral fat—tied to inflammation, heart disease, and diabetes—sheds first during a fasting window and continues to decline with refeeding. The conversation links these changes to a broader shift away from processed foods that load the brain with dopamine-boosting salt, oil, and sugar, and toward a whole-plant SOS-free diet. Intermittent fasting and time-restricted feeding are offered as practical tools: avoid eating within three to four hours of sleep, extend the fast to sixteen hours when possible, and tailor the feeding window to individual needs, activity, and caloric goals. Clinical outcomes anchor the discussion: hypertension can normalize with two weeks of fasting, and long-term follow-ups show many maintain normal blood pressure off medications after refeeding and lifestyle changes. Lymphoma and polycystic ovarian syndrome appear responsive, with case reports and series indicating tumor regression and improved reproductive function during and after fasting. Beyond disease, healthy individuals may gain reduced visceral fat and lower cholesterol, though shorter fasts are suggested for prevention. Safety remains essential: patients are screened, monitored, and refeed gradually to avoid refeeding syndrome, and long-duration fasts require supervision. The broader message is that fasting reshapes physiology and behavior, including taste perception and reward pathways, helping people reset habits toward a plant-based, SOS-free lifestyle.